Paxil and Lymphoma - a phase IV clinical study of FDA data

Summary:

Lymphoma is reported as a side effect among people who take Paxil (paroxetine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Lymphoma when taking Paxil. It is created by eHealthMe based on reports of 88,676 people who have side effects when taking Paxil from the FDA, and is updated regularly.

What is Paxil?

Paxil has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 92,546 Paxil users. Check the latest studies of Paxil.

What is Lymphoma?

Lymphoma (cancer that begins in immune system cells) is found to be associated with 961 drugs and 1,015 conditions by eHealthMe. Check the latest studies of Lymphoma.

On Jul, 16, 2026

88,676 people reported to have side effects when taking Paxil.
Among them, 38 people (0.04%) have Lymphoma.

Among these 38 people:

How long have people been on Paxil when they have Lymphoma? *

What is the gender of people who have Lymphoma when taking Paxil? *

female: 56.76 %
male: 43.24 %

What is the age of people who have Lymphoma when taking Paxil? *

What are other drugs people take besides Paxil? *

What are other side effects people have besides Lymphoma? *

Anaemia (lack of blood): 14 people, 36.84%
Pneumonia: 13 people, 34.21%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 11 people, 28.95%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 10 people, 26.32%
Pleural Effusion (water on the lungs): 10 people, 26.32%
Osteomyelitis (infection of bone): 8 people, 21.05%
Thrombocytopenia (decrease of platelets in blood): 8 people, 21.05%
Cardiac Failure Congestive: 8 people, 21.05%
Dizziness: 8 people, 21.05%
Back Pain: 8 people, 21.05%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 18.42%
Hiv Infection: 4 people, 10.53%
Bone Disorder: 4 people, 10.53%
High Blood Pressure: 3 people, 7.89%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.89%
Multiple Myeloma (cancer of the plasma cells): 3 people, 7.89%
Constipation: 2 people, 5.26%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 5.26%
Depressive Symptom: 2 people, 5.26%
Diabetes: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Paxil and have Lymphoma?

- Check whether Lymphoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paxil:

Paxil (92,546 reports)

Lymphoma treatments and more:

Lymphoma (33,395 reports)

Browse all side effects of Paxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphoma:

Lymphoma (961 drugs)

Browse all the conditions that are associated with Lymphoma:

Lymphoma (1,015 conditions)

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on paroxetine hydrochloride (the active ingredients of Paxil) and Paxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.